MSFT
Microsoft Corporation
MSFT has the edge over XPER overall, supported by stronger valuation and stronger modeled upside.
XPER
Xperi Inc.
XPER's outlook is improving, though it still trails on the overall score.
MSFT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MSFT's revenue, profitability, cash flow and balance sheet are all currently healthy.
XPER Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Healthy |
XPER's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
MSFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 25x | $523 | — |
| Cheap | 27x | $525 | +0.4% |
| Current | 27x | $523 | — |
| Fair | 34x | $652 | +25% |
| Expensive | 37x | $711 | +36% |
Historical ranges are pointers, not guarantees.
MSFT's PE is in its cheap range at 27x. If earnings grow as analysts expect, today's price would be 25x next year's earnings.
XPER PE Valuation
XPER has no meaningful PE right now: it lost money over the past year.
MSFT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for MSFT, with profitability holding steady.
XPER Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
XPER has the edge over MSFT on the outlook, with more favorable profitability expectations.
MSFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.79 | +8.6% |
| Q3 2026 | $19.15 | +36% |
| Q2 2026 | $17.95 | +32% |
| Q1 2026 | $16.80 | +30% |
| Q4 2025 | $15.99 | +29% |
| Q3 2025 | $14.06 | +16% |
| Q2 2025 | $13.64 | +16% |
| Q1 2025 | $12.93 | +12% |
| Q4 2024 | $12.41 | +12% |
MSFT has the edge over XPER on earnings quality, reporting a profit while its opponent remains loss making.
XPER Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.07 | — |
| Q3 2026 | -$0.68 | -525% |
| Q2 2026 | -$0.70 | -$0.62 |
| Q1 2026 | -$0.99 | -$0.56 |
| Q4 2025 | -$1.23 | -$0.92 |
| Q3 2025 | $0.16 | +$2.05 |
| Q2 2025 | -$0.08 | +$2.40 |
| Q1 2025 | -$0.43 | +$2.28 |
| Q4 2024 | -$0.31 | +$2.87 |
XPER has swung to a loss: it lost $0.68 per share over the past year, after a profit the year before.
MSFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $92.3B | +19% |
| Q2 2026 | $90B | +18% |
| Q1 2026 | $82.9B | +18% |
| Q4 2025 | $81.3B | +17% |
| Q3 2025 | $77.7B | +18% |
| Q2 2025 | $76.4B | +18% |
| Q1 2025 | $70.1B | +13% |
| Q4 2024 | $69.6B | +12% |
MSFT has the edge over XPER on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +0.9 points |
| Q2 2026 | 45% | +0.2 points |
| Q1 2026 | 46% | +0.7 points |
| Q4 2025 | 47% | +1.6 points |
| Q3 2025 | 49% | +2.3 points |
| Q2 2025 | 45% | +1.8 points |
| Q1 2025 | 46% | +1.1 points |
| Q4 2024 | 45% | +1.9 points |
MSFT has the edge over XPER on profitability, with a higher operating margin.
XPER Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $114M | +2.1% |
| Q2 2026 | $114.5M | +8.1% |
| Q1 2026 | $114.2M | +0.2% |
| Q4 2025 | $116.5M | -4.8% |
| Q3 2025 | $111.6M | -16% |
| Q2 2025 | $105.9M | -11% |
| Q1 2025 | $114M | -4% |
| Q4 2024 | $122.4M | -11% |
XPER's revenue fell from its 2020 peak and has held roughly level since: $114M last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.6% | +2.8 points |
| Q2 2026 | 2.5% | +13 points |
| Q1 2026 | 1.9% | +16 points |
| Q4 2025 | -13% | -1 points |
| Q3 2025 | -1.2% | +13 points |
| Q2 2025 | -11% | +7.8 points |
| Q1 2025 | -14% | +13 points |
| Q4 2024 | -12% | +10 points |
XPER's operating margin was 1.6% last quarter, up 2.8 points from the same quarter a year ago.
MSFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.6B | -27% |
| Q2 2026 | $19.6B | -23% |
| Q1 2026 | $15.8B | -22% |
| Q4 2025 | $5.9B | -9.3% |
| Q3 2025 | $25.7B | +33% |
| Q2 2025 | $25.6B | +9.6% |
| Q1 2025 | $20.3B | -3.2% |
| Q4 2024 | $6.5B | -29% |
MSFT has the edge over XPER on cash generation, producing positive trailing cash flow while its opponent burns cash.
XPER Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.3M | -51% |
| Q2 2026 | $14.1M | +47% |
| Q1 2026 | -$19.1M | +$4.2M |
| Q4 2025 | $1.2M | +$1.7M |
| Q3 2025 | $6.7M | +$12.4M |
| Q2 2025 | $9.5M | +$12.1M |
| Q1 2025 | -$23.3M | +$28.3M |
| Q4 2024 | -$510K | -103% |
XPER's free cash flow was −$633,000 over the past year, against −$8M the year before.
MSFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
MSFT's net debt is less than a year of its operating earnings (EBITDA).
XPER Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.2x | Net Cash |
| Q2 2026 | -1.4x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -12.5x | Net Cash |
| Q3 2025 | -8.5x | Net Cash |
| Q3 2021 | 2.9x | Moderate |
| Q2 2021 | 2.5x | Moderate |
| Q1 2021 | 2.6x | Moderate |
XPER has the edge over MSFT on leverage, with a lower net debt burden relative to earnings.
MSFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 68.0 | Neutral |
MSFT's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).
XPER Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.8 | Neutral |
| Stochastic | 30.8 | Neutral |
XPER's weekly RSI is 50 (neutral) and its Stochastic is 31 (neutral).
MSFT PE vs Technology Sector
| Metric | MSFT | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 28x | 2% below |
| PE % | 16 | 35 | 19 pts below |
MSFT is trading at 27x earnings, in line with the Technology sector's median of 28x.
XPER PE vs Technology Sector
| Metric | XPER | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
XPER has no meaningful PE right now: it lost money over the past year.
MSFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $524.7 | 0.3% below |
| 20 week MA | $484.8 | 7.9% above |
| 50 week MA | $446.9 | 17% above |
| 100 week MA | $453.8 | 15% above |
| 200 week MA | $411.5 | 27% above |
MSFT has the edge over XPER on trend strength, trading above more of its moving averages.
XPER Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.44 | 13% above |
| 20 week MA | $6.27 | 1.9% below |
| 50 week MA | $6.37 | 3.5% below |
| 100 week MA | $6.94 | 11% below |
| 200 week MA | $8.51 | 28% below |
XPER has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 28% below its 200-week average.
MSFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $159.0 | $222.8 | +40% |
| 2021 | $222.8 | $334.7 | +50% |
| 2022 | $334.7 | $238.7 | -29% |
| 2023 | $238.7 | $376.0 | +58% |
| 2024 | $376.0 | $430.5 | +14% |
| 2025 | $430.5 | $487.7 | +13% |
| 2026 YTD | $487.7 | $523.0 | +7.2% |
MSFT has the edge over XPER on returns for 2026, with the stronger performance.
XPER Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $14.8 | $8.35 | -44% |
| 2023 | $8.35 | $11.0 | +32% |
| 2024 | $11.0 | $10.1 | -8.1% |
| 2025 | $10.1 | $5.93 | -41% |
| 2026 YTD | $5.93 | $6.15 | +3.7% |
XPER has finished lower in three of the last four years. It's up 3.7% so far in 2026.